Xiamen Amoytop Biotech Hits Day Low of CNY 57 Amid Price Pressure

Xiamen Amoytop Biotech Co. experienced a notable decline today, with the stock dropping by 4.58% and hitting an intraday low of CNY 57.00. This performance contrasts with the broader market, as the China Shanghai Composite index fell by 3.05% on the same day. Despite the day's downturn, Xiamen Amoytop has shown resilience over the past week, gaining 3.29%, while the Shanghai Composite has decreased by 5.81%. Over the past month, the stock has increased by 5.44%, outperforming the index, which has seen an 8.37% decline. However, the one-year performance reveals a different story, with Xiamen Amoytop down 24.95%, significantly lagging behind the Shanghai Composite's 7.03% gain. Year-to-date, the stock has also underperformed, showing a decline of 31.25% compared to the index's 5.16% drop. Financially, the company has reported strong metrics, including a net sales figure of CNY 1,216.02 million and an operating profit of CNY 472.2 million. With a return on equity of 34.50% and a price-to-book ratio of 12.11, Xiamen Amoytop maintains a solid financial foundation despite recent stock performance challenges.